Lee Ainslie's TECH Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 3.0M shares of Bio-Techne Corporation (TECH) worth $167.59 M, representing 2.24% of the portfolio. First purchased in 2019-Q4, this long-term strategic position has been held for 24 quarters.
Based on 13F filings, Lee Ainslie has maintained a strategic position in TECH, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 2.5M shares. Largest reduction occurred in Q2 2020, reducing 32.1K shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's Bio-Techne Corporation (TECH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bio-Techne Corporation (TECH) Trades by Lee Ainslie
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2019 | +36,916 | New Buy | 36,916 | $54.88 |
| Q1 2020 | -3,284 | Reduce 8.90% | 33,632 | $47.40 |
| Q2 2020 | -32,076 | Reduce 95.37% | 1,556 | $66.20 |
| Q3 2020 | +1,272 | Add 81.75% | 2,828 | $61.88 |
| Q4 2020 | +5,916 | Add 209.19% | 8,744 | $79.37 |
| Q1 2021 | -2,640 | Reduce 30.19% | 6,104 | $95.51 |
| Q2 2021 | -6,104 | Sold Out | 6,104 | $0.00 |
| Q1 2025 | +522,897 | New Buy | 522,897 | $58.63 |
| Q2 2025 | -522,897 | Sold Out | 522,897 | $0.00 |
| Q3 2025 | +3.01 M | New Buy | 3.01 M | $55.63 |
Lee Ainslie's Bio-Techne Corporation Investment FAQs
Lee Ainslie first purchased Bio-Techne Corporation (TECH) in Q4 2019, acquiring 36,916 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held Bio-Techne Corporation (TECH) for 24 quarters since Q4 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie's largest addition to Bio-Techne Corporation (TECH) was in Q3 2025, adding 3,012,654 shares worth $167.59 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Lee Ainslie's firm, Maverick Capital LTD, owns 3,012,654 shares of Bio-Techne Corporation (TECH), valued at approximately $167.59 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Bio-Techne Corporation (TECH) represents approximately 2.24% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie's peak holding in Bio-Techne Corporation (TECH) was 3,012,654 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.